Customizing Maxpar Direct Immune Profiling Assay with Additional Surface Marker and Intracellular Cytokine Staining Workflows for Expanded Mass Cytometry Panels.


Journal

Methods in molecular biology (Clifton, N.J.)
ISSN: 1940-6029
Titre abrégé: Methods Mol Biol
Pays: United States
ID NLM: 9214969

Informations de publication

Date de publication:
2022
Historique:
entrez: 12 11 2021
pubmed: 13 11 2021
medline: 8 1 2022
Statut: ppublish

Résumé

Mass cytometry, or cytometry by time-of-flight (the basis for Fluidigm

Identifiants

pubmed: 34766269
doi: 10.1007/978-1-0716-1771-7_9
doi:

Substances chimiques

Antibodies 0
Biomarkers 0
Cytokines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

129-145

Informations de copyright

© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Bagwell CB (2020) Multi-site reproducibility of a human immunophenotyping assay in whole blood and peripheral blood mononuclear cells preparations using CyTOF technology coupled with Maxpar Pathsetter, an automated data analysis system. Cytometry B Clin Cytom 98(2):146–160. https://doi.org/10.1002/cyto.b.21858
doi: 10.1002/cyto.b.21858 pubmed: 31758746
Fluidigm Corporation (2020) Maxpar direct immune profiling assay cell staining and data acquisition user guide (400286)
Fluidigm Corporation (2020) Maxpar cytoplasmic/secreted antigen staining with fresh fix (400279)
Fluidigm Corporation (2019) Maxpar antibody labeling user guide (PRD002)
Fluidigm Corporation (2020) Helios, a CyTOF System User Guide (400250)
Fluidigm Corporation (2019) Technical note: approach to bivariate analysis of data acquired using the Maxpar direct immune profiling assay (400248)
Fluidigm Corporation (2020) Maxpar Panel Designer User Guide (100-9557).
Fluidigm Corporation (2020) Impact of cryopreservation on performance of the Maxpar direct immune profiling system (FLDM-00089).

Auteurs

Carlene Petes (C)

Fluidigm Canada Inc., Markham, ON, Canada. carlene.petes@fluidigm.com.

Stephen K H Li (SKH)

Fluidigm Canada Inc., Markham, ON, Canada.

Shariq Mujib (S)

Fluidigm Canada Inc., Markham, ON, Canada.

Michelle M Poulin (MM)

Fluidigm Corporation, South San Francisco, CA, USA.

Noah Saederup (N)

Fluidigm Corporation, South San Francisco, CA, USA.

Andrew A Quong (AA)

Fluidigm Corporation, South San Francisco, CA, USA.

Christina Loh (C)

Fluidigm Canada Inc., Markham, ON, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH